LLS backs 5 new cancer drug projects with up to $50M; Trodelvy continues to impress with more TNBC data
The Leukemia and Lymphoma Society has tapped 5 new early-stage projects to back with up to $10 million each in fresh …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
